anmelden
SLI
2.310,49
PKT
-7,82
PKT
-0,34
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.04.20 | Roche buy | Jefferies & Company Inc. | |
| 15.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 15.04.20 | Nestlé Neutral | Credit Suisse Group | |
| 14.04.20 | Nestlé add | Baader Bank | |
| 14.04.20 | Zurich Insurance Hold | Kepler Cheuvreux | |
| 14.04.20 | UBS Underweight | Barclays Capital | |
| 14.04.20 | UBS Underweight | Barclays Capital | |
| 09.04.20 | Swiss Re Hold | Jefferies & Company Inc. | |
| 09.04.20 | Givaudan Underperform | Credit Suisse Group | |
| 09.04.20 | UBS Sector Perform | RBC Capital Markets | |
| 09.04.20 | UBS Sector Perform | RBC Capital Markets | |
| 09.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 09.04.20 | UBS overweight | Morgan Stanley | |
| 09.04.20 | UBS Equal-Weight | Morgan Stanley | |
| 09.04.20 | Nestlé overweight | Morgan Stanley | |
| 09.04.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 09.04.20 | UBS buy | Kepler Cheuvreux | |
| 09.04.20 | Roche overweight | Barclays Capital | |
| 09.04.20 | UBS Outperform | Credit Suisse Group | |
| 09.04.20 | Zurich Insurance Outperform | Credit Suisse Group | |
| 09.04.20 | Swiss Re Outperform | Credit Suisse Group | |
| 09.04.20 | Givaudan buy | UBS AG | |
| 08.04.20 | Givaudan Underperform | Credit Suisse Group | |
| 08.04.20 | Givaudan buy | UBS AG | |
| 08.04.20 | UBS buy | UBS AG | |
| 08.04.20 | Givaudan add | Baader Bank | |
| 08.04.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 08.04.20 | Holcim buy | Oddo BHF | |
| 08.04.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 08.04.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 08.04.20 | Givaudan Underperform | Bernstein Research | |
| 08.04.20 | Nestlé Hold | HSBC | |
| 08.04.20 | Holcim kaufen | JP Morgan Chase & Co. | |
| 07.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 07.04.20 | Givaudan Underweight | Barclays Capital | |
| 07.04.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 07.04.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.04.20 | Holcim buy | Goldman Sachs Group Inc. |
